Dr. Anand Srivastava, M.S., Ph.D.
Chairman, Co-Founder & Chief Scientific Officer
Dr. Anand Srivastava serves as Chairman, Co-Founder, and Chief Scientific Officer for Stem Cells Costa Rica, guiding scientific direction and supporting the development of research-aligned regenerative protocols for patients exploring advanced stem cell therapy in Costa Rica.
Globally recognized for his contributions to stem cell biology, translational research, and clinical innovation, Dr. Srivastava has dedicated decades to advancing regenerative medicine through published research, international scientific leadership, and multidisciplinary discovery.
Award-Winning Scientific Leadership
Dr. Srivastava’s scientific impact has been recognized with more than 10 awards and fellowships honoring his contributions to stem cell science, regenerative medicine, and clinical research.
His most notable recognitions include:
- SAASCR Outstanding Achievement Award (2020) — recognized alongside leading cancer researchers in the United States
- Two consecutive STA/JISTEC Awards (Japan) — prestigious international research fellowships from the Government of Japan
- USA Congressional Recognition (2014) — awarded for contributions to Stem Cell Science
- Asian Heritage Award (2013) — for leadership in stem cell research
- Excellent Poster / Presentation Award (Kyoto, Japan) — Meeting of Clinical Chemistry and Laboratory Medicine
- Featured in “Who’s Who in America” (2005, 2010) for scientific impact and recognition
75+ Peer-Reviewed Publications & Global Scientific Impact
Dr. Srivastava has authored 75+ peer-reviewed scientific articles spanning regenerative medicine, immunology, gene therapy, and stem cell translation—supporting the field’s progress from discovery to real-world clinical application.
Notably, leading scientific journals have devoted special stem cell issues to his work, including:
- Current Topics in Medicinal Chemistry (special issue, 2010)
- Stem Cell International (special issue, 2012)
Major Scientific Contributions
Dr. Srivastava has contributed foundational research in stem cell science, including early work in:
- serum-free, animal material-free embryonic stem cell culture conditions
- in utero stem cell transplantation and fetal tolerance induction
- mechanisms regulating stem cell differentiation into hematopoietic and neural cells
- models demonstrating stem cell migration to damaged brain tissue and injured organs
- targeted delivery strategies using tissue receptor binding peptides to improve precision medicine approaches
- translational research supporting regenerative approaches for autoimmune disease, neurological injury, and tissue repair
These achievements reflect a rare combination of deep scientific depth and broad multidisciplinary expertise.
Areas of Expertise
- Stem Cell Biology & Translational Research
- Molecular Biology & Immunology
- Tissue Targeting Strategies
- Protein Biochemistry
- Gene Therapy & Regenerative Mechanisms
- Clinical Development Support for Stem Cell-Based Therapies
Dr. Srivastava’s Role at Stem Cells Costa Rica
As Chief Scientific Officer, Dr. Srivastava supports the program by:
- Advising on research-informed regenerative protocols
- Supporting safety-focused clinical considerations
- Contributing to treatment strategy development
- Helping maintain high scientific standards aligned with ongoing research